| P2093 | author name string | K Krüger | |
| | M Schattenkirchner | |
| | K Beck | |
| | F C Breedveld | |
| | C F Allaart | |
| | R Rau | |
| | P L C M van Riel | |
| | J Kempeni | |
| | H Kupper | |
| | L B A van de Putte | |
| | S Simianer | |
| P2860 | cites work | The american rheumatism association 1987 revised criteria for the classification of rheumatoid arthritis | Q27860872 |
| | Adalimumab, a fully human anti-tumor necrosis factor alpha monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: the ARMADA trial | Q34530459 |
| | Long term anti-tumour necrosis factor alpha monotherapy in rheumatoid arthritis: effect on radiological course and prognostic value of markers of cartilage turnover and endothelial activation. | Q35551481 |
| | Efficacy, pharmacokinetic, and safety assessment of adalimumab, a fully human anti-tumor necrosis factor-alpha monoclonal antibody, in adults with rheumatoid arthritis receiving concomitant methotrexate: a pilot study | Q42603607 |
| | The relationship between disease activity, joint destruction, and functional capacity over the course of rheumatoid arthritis | Q42661052 |
| | Drug survival, efficacy and toxicity of monotherapy with a fully human anti-tumour necrosis factor-alpha antibody compared with methotrexate in long-standing rheumatoid arthritis | Q43964784 |
| | American College of Rheumatology. Preliminary definition of improvement in rheumatoid arthritis | Q47643186 |
| | Guidelines for the management of rheumatoid arthritis: 2002 Update | Q56212157 |
| P433 | issue | 3 | |
| P921 | main subject | rheumatoid arthritis | Q187255 |
| | adalimumab | Q348260 |
| P304 | page(s) | 145-153 | |
| P577 | publication date | 2004-01-01 | |
| P1433 | published in | Scandinavian Journal of Rheumatology | Q15767622 |
| P1476 | title | Rapid alleviation of signs and symptoms of rheumatoid arthritis with intravenous or subcutaneous administration of adalimumab in combination with methotrexate | |
| P478 | volume | 33 | |